|
1. FDA rejects full approval of liver disease drug Full story
2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story
3. President-elect Trump taps Dr. Oz for CMS administrator: 10 things to know Full story
4. Health systems share proven strategies to expand infusion access. Join them here.
5. Eli Lilly drug cuts genetic form of cholesterol by 86%: Study Full story
6. 53% of US adults are eligible for Ozempic, Wegovy: Study Full story
7. Rare diseases can be hard to identify. Discover what some health systems are doing to improve care pathways for these patients here.
8. Eli Lilly, Novo Nordisk urge employers to cover cost of weight loss drugs Full story
Becker's Learning Opportunities
9. Forward-looking CIOs are bringing computer vision to their hospitals. Find out why (and how) here.
10. 13 must-ask Qs to set the highest cleanliness standards at your hospital — get them here.
11. Cancer care innovation is outpacing adoption. Catch up with best-practice testing protocol — here.
|
.png)
